RHHBF - Novartis To Axe 680 Development Jobs Amid Global Reshuffle: Report | Benzinga
Novartis AG (NYSE:NVS) reportedly plans to slash up to 680 positions in its development organization, aiding in drug market launches.
The Basel-based company announced that approximately 440 positions will be cut in Switzerland and up to 240 in the U.S. within the next two to three years, Reuters reported.
The job cuts mentioned are distinct from a restructuring initiative that may result in up to 8,000 positions being eliminated from Novartis’s global workforce of 78,000, the report ...